First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure - Archive ouverte HAL Access content directly
Journal Articles Antiviral Research Year : 2022

First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure

(1) , (2) , (3, 4) , (5) , (6) , (7, 8) , (9, 10) , (11, 12) , (1, 13) , (1, 13)
1
2
3
4
5
6
7
8
9
10
11
12
13
Not file

Dates and versions

hal-03851053 , version 1 (14-11-2022)

Identifiers

Cite

Clotilde Muller, Valentin Tilloy, Emilie Frobert, Linda Feghoul, Isabelle Garrigue, et al.. First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure. Antiviral Research, 2022, 204, pp.105361. ⟨10.1016/j.antiviral.2022.105361⟩. ⟨hal-03851053⟩
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More